SCHEMBL7158461

SCHEMBL7158461

COc1ccc2cc(C=C(C#N)C#N)ccc2c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.72
ALDH1A1 P00352 5/20 0.72
KDM4E B2RXH2 5/20 0.72
CYP1A2 P05177 4/20 0.72
CYP3A4 P08684 3/20 0.72
HPGD P15428 3/20 0.72
NFKB1 P19838 3/20 0.72
BLM P54132 3/20 0.72
PMP22 Q01453 3/20 0.72
NPSR1 Q6W5P4 2/20 0.72
TSHR P16473 2/20 0.72
APEX1 P27695 1/20 0.72
EGFR P00533 7/20 0.58
MEN1 O00255 6/20 0.52
KMT2A Q03164 6/20 0.52
LMNA P02545 3/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 2/20 0.50
ALOX15 P16050 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11313166 0.86 ALDH1A1 (0.70) MAPTALDH1A1KDM4ECYP1A2CYP3A4
Tyrphostin 1 SCHEMBL1982746 0.84 MAPT (1.00) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL2180188 0.81 MAPT (0.64) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL11442633 0.79 ALDH1A1 (0.59) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL29981112 0.79 ALDH1A1 (0.59) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL13484115 0.79 CYP1A2 (0.50) KDM4ECYP1A2TSHRLMNACYP19A1
SCHEMBL2719499 0.77 NQO1 (0.49) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL7345665 0.77 RELA (0.49) MAPTALDH1A1KDM4ECYP1A2HPGD
SCHEMBL27960908 0.77 ALDH1A1 (0.67) MAPTALDH1A1KDM4ECYP1A2CYP3A4
SCHEMBL14095625 0.76 MAPT (0.46) MAPTALDH1A1KDM4ECYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6538161-B2 Naphthalene skeleton substituted with a 1- or 2- position electron donating group and a 6- or 4- position electron attractive group; emitts visible light with a desired color by choosing appropriate combinations TAIHO INDUSTRIES CO., LTD. (JP) 2003-03-25 US disclosed
US-20020156319-A1 Fluorescent compounds HIROSE ENGINEERING CO., LTD. (JP) 2002-10-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156319-A1 Fluorescent compounds NES, NDC1, DYNC1LI2 MAPT 1251/4885ALDH1A1 1215/4885KDM4E 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.